IL37 and atherosclerosis: On the other hand, ablation of IL-22 in hematopoietic cells heightened atherosclerosis in a mouse model, while administration of an IL-22-Ig-stabilized recombinant cytokine suppressed the disease development in Ldlr−/− and IL-23-deficient Ldlr−/− animals [71].